This month’s executive moves span a diverse range of organisations – from CDMOs and genomics platforms to diagnostics and digital health firms – highlighting the evolving landscape of pharm
Digital interactions increasingly shape how we engage with brands, yet the ones that leave the strongest impression often do so by being almost invisible.
Hundreds of senior executives representing major pharma companies met last month at Axtria Ignite 2025 to discuss the future of agentic AI in the industry.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.